HUMA Humacyte, Inc.
$0.50
Humacyte, Inc. (HUMA) Earnings News
Earnings press releases, previews and reviews for Humacyte, Inc. (HUMA), newest first. Our most recent is review: Humacyte Beats as Symvess Sales More Than Double, but Dilution, Negative Gross Margin and Shrinking Cash Shadow the Inflection.
Tuesday
November 10, 2026
10:47 AM ET
Humacyte Beats as Symvess Sales More Than Double, but Dilution, Negative Gross Margin and Shrinking Cash Shadow the Inflection
Earnings Whispers · Review
Tuesday
November 10, 2026
7:00 AM ET
Humacyte Reports Third Quarter 2026 Results, Highlighted by More Than Doubling Symvess Revenue and Expanding Commercial Adoption
Tuesday
November 3, 2026
12:05 AM ET
Humacyte Heads Into Q3 Needing Proof Its Rebuilt Trauma Launch Works as Dialysis Filing Nears
Earnings Whispers · Preview
Monday
November 2, 2026
8:00 AM ET
Humacyte To Announce 2026 Third Quarter Financial Results and Provide Business Update on November 10, 2026
Wednesday
August 12, 2026
7:00 AM ET
Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
Friday
August 7, 2026
8:00 AM ET
Humacyte To Announce 2026 Second Quarter Financial Results and Provide Business Update on August 12, 2026